These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 29028335)
1. Metallo-supramolecular Complexes Enantioselectively Eradicate Cancer Stem Cells in Vivo. Qin H; Zhao C; Sun Y; Ren J; Qu X J Am Chem Soc; 2017 Nov; 139(45):16201-16209. PubMed ID: 29028335 [TBL] [Abstract][Full Text] [Related]
2. G-Quadruplex binding enantiomers show chiral selective interactions with human telomere. Wang J; Chen Y; Ren J; Zhao C; Qu X Nucleic Acids Res; 2014 Apr; 42(6):3792-802. PubMed ID: 24413564 [TBL] [Abstract][Full Text] [Related]
3. The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2+ breast cancer cells. Koziel JE; Herbert BS Breast Cancer Res Treat; 2015 Feb; 149(3):607-18. PubMed ID: 25627551 [TBL] [Abstract][Full Text] [Related]
4. Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity. Bonuccelli G; Peiris-Pages M; Ozsvari B; Martinez-Outschoorn UE; Sotgia F; Lisanti MP Oncotarget; 2017 Feb; 8(6):9868-9884. PubMed ID: 28039467 [TBL] [Abstract][Full Text] [Related]
5. Telomere targeting with a novel G-quadruplex-interactive ligand BRACO-19 induces T-loop disassembly and telomerase displacement in human glioblastoma cells. Zhou G; Liu X; Li Y; Xu S; Ma C; Wu X; Cheng Y; Yu Z; Zhao G; Chen Y Oncotarget; 2016 Mar; 7(12):14925-39. PubMed ID: 26908447 [TBL] [Abstract][Full Text] [Related]
6. The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines. Joseph I; Tressler R; Bassett E; Harley C; Buseman CM; Pattamatta P; Wright WE; Shay JW; Go NF Cancer Res; 2010 Nov; 70(22):9494-504. PubMed ID: 21062983 [TBL] [Abstract][Full Text] [Related]
7. Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism. Phatak P; Cookson JC; Dai F; Smith V; Gartenhaus RB; Stevens MF; Burger AM Br J Cancer; 2007 Apr; 96(8):1223-33. PubMed ID: 17406367 [TBL] [Abstract][Full Text] [Related]
8. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function. Burger AM; Dai F; Schultes CM; Reszka AP; Moore MJ; Double JA; Neidle S Cancer Res; 2005 Feb; 65(4):1489-96. PubMed ID: 15735037 [TBL] [Abstract][Full Text] [Related]
9. A 1,10-phenanthroline derivative selectively targeting telomeric G-quadruplex induces cytoprotective autophagy, causing apoptosis of gastric cancer cells. Ma X; Awadasseid A; Zhou K; Wang X; Shen C; Zhao X; Cheng M; Zhang W Life Sci; 2021 Dec; 287():120095. PubMed ID: 34715135 [TBL] [Abstract][Full Text] [Related]
10. NMI inhibits cancer stem cell traits by downregulating hTERT in breast cancer. Feng X; Xu X; Xiao X; Zou K; Yu W; Wu J; Tang R; Gao Y; Hao J; Zhao X; Liao Y; Chen Y; Huang W; Guo W; Kang L; Deng W Cell Death Dis; 2017 May; 8(5):e2783. PubMed ID: 28492540 [TBL] [Abstract][Full Text] [Related]
11. A2B adenosine receptor agonist induces cell cycle arrest and apoptosis in breast cancer stem cells via ERK1/2 phosphorylation. Jafari SM; Joshaghani HR; Panjehpour M; Aghaei M Cell Oncol (Dordr); 2018 Feb; 41(1):61-72. PubMed ID: 29218545 [TBL] [Abstract][Full Text] [Related]
12. Telomerase and drug resistance in cancer. Lipinska N; Romaniuk A; Paszel-Jaworska A; Toton E; Kopczynski P; Rubis B Cell Mol Life Sci; 2017 Nov; 74(22):4121-4132. PubMed ID: 28623509 [TBL] [Abstract][Full Text] [Related]
13. Chiral metallohelices enantioselectively target hybrid human telomeric G-quadruplex DNA. Zhao A; Howson SE; Zhao C; Ren J; Scott P; Wang C; Qu X Nucleic Acids Res; 2017 May; 45(9):5026-5035. PubMed ID: 28398500 [TBL] [Abstract][Full Text] [Related]
14. Glycophenotype of breast and prostate cancer stem cells treated with thieno[2,3- Mastelić A; Čikeš Čulić V; Režić Mužinić N; Vuica-Ross M; Barker D; Leung EY; Reynisson J; Markotić A Drug Des Devel Ther; 2017; 11():759-769. PubMed ID: 28352152 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors. Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842 [TBL] [Abstract][Full Text] [Related]
16. Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway. Yang J; Liao D; Chen C; Liu Y; Chuang TH; Xiang R; Markowitz D; Reisfeld RA; Luo Y Stem Cells; 2013 Feb; 31(2):248-58. PubMed ID: 23169551 [TBL] [Abstract][Full Text] [Related]
17. 4EGI-1 targets breast cancer stem cells by selective inhibition of translation that persists in CSC maintenance, proliferation and metastasis. Yi T; Kabha E; Papadopoulos E; Wagner G Oncotarget; 2014 Aug; 5(15):6028-37. PubMed ID: 25115391 [TBL] [Abstract][Full Text] [Related]
18. Correlation between telomerase and mTOR pathway in cancer stem cells. Dogan F; Biray Avci C Gene; 2018 Jan; 641():235-239. PubMed ID: 29074462 [TBL] [Abstract][Full Text] [Related]
19. Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells. Koike Y; Ohta Y; Saitoh W; Yamashita T; Kanomata N; Moriya T; Kurebayashi J Breast Cancer; 2017 Sep; 24(5):683-693. PubMed ID: 28144905 [TBL] [Abstract][Full Text] [Related]
20. G-quadruplex ligand-induced DNA damage response coupled with telomere dysfunction and replication stress in glioma stem cells. Hasegawa D; Okabe S; Okamoto K; Nakano I; Shin-ya K; Seimiya H Biochem Biophys Res Commun; 2016 Feb; 471(1):75-81. PubMed ID: 26845351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]